Combination of the Hypercvad Regimen with Dasatinib Is Effective in Patients with Relapsed Philadelphia Chromosome (Ph) Positive Acute Lymphoblastic Leukemia (ALL) and Lymphoid Blast Phase Chronic Myeloid Leukemia (CML-LB).

被引：25
|
作者：
Ravandi, Farhad
Kantarjian, Hagop M.
Cortes, Jorge
Thomas, Deborah A.
Faderl, Stefan
Jones, Dan
Jabbour, Elias [1 ]
Koller, Charles
Dara, Samuel [1 ]
Garris, Rebecca
Kebriaei, Partow
Borthakur, Gautam
Ferrajoli, Alessandra
O'Brien, Susan
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
来源：
BLOOD | 2009年 / 114卷 / 22期
关键词：
D O I：
10.1182/blood.V114.22.636.636
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：806 / 807
页数：2
相关论文
共 50 条
  • [21] Nilotinib in Pediatric Patients with Philadelphia Chromosome-Positive (PH plus ) Chronic Myeloid Leukemia (CML) or PH plus Acute Lymphoblastic Leukemia (ALL): a Pharmacokinetic Study
    Hijiya, Nobuko
    Zwaan, C. Michel
    Rizzari, Carmelo
    Foa, Roberto
    Abbink, Floor
    Lancaster, Donna
    Landman-Parker, Judith
    Millot, Frederic
    Moppett, John
    Nelken, Brigitte
    Ducassou, Stephane
    Putti, Maria Caterina
    Tian, Xianbin
    Sinclair, Karen
    Santanastasio, Helene
    Buchbinder, Aby
    Kearns, Pamela
    PEDIATRIC BLOOD & CANCER, 2017, 64 : S34 - S34
  • [22] Ponatinib and Blinatumomab for Patients with Relapsed/Refractory Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia or Chronic Myeloid Leukemia in Lymphoid Blast Phase: A Subgroup Analysis from a Phase II Study
    Macaron, Walid
    Kantarjian, Hagop
    Short, Nicholas
    Jain, Nitin
    Huang, Xuelin
    Montalban-Bravo, Guillermo
    Kadia, Tapan M.
    Daver, Naval
    Chien, Kelly S.
    Alvarado, Yesid
    Garcia-Manero, Guillermo
    Issa, Ghayas C.
    Haddad, Fadi
    Kwari, Monica
    Delumpa, Ricardo
    Mayor, Ejiroghene
    Deen, Wuliamatu
    Thankachan, Jennifer
    Loiselle, Christopher
    Rivera, Juan
    Milton, Anna
    Waller, Lourdes
    Banks, Glenda
    Garris, Rebecca
    Konopleva, Marina
    Ravandi, Farhad
    Jabbour, Elias
    BLOOD, 2022, 140 : 8973 - 8975
  • [23] Dynamics of Minimal Residual Leukemia After Combinations of the HyperCVAD Regimen with Imatinib or Dasatinib In Patients with Philadelphia-Chromosome Positive Acute Lymphoblastic Leukemia.
    Ravandi, Farhad
    Thomas, Deborah A.
    O'Brien, Susan
    Faderl, Stefan
    Jorgensen, Jeffrey
    Luthra, Rajyalakshmi
    Jones, Dan
    Garris, Rebecca
    Cortes, Jorge E.
    Kantarjian, Hagop
    BLOOD, 2010, 116 (21) : 879 - 879
  • [24] A Phase II Study of the Combination of Decitabine, Venetoclax and Ponatinib in Patients with Chronic Myeloid Leukemia (CML) in Myeloid Blast Phase (MBP) or Philadelphia-Chromosome Positive (Ph plus ) Acute Myeloid Leukemia (AML)
    Senapati, Jayastu
    Ravandi, Farhad
    DiNardo, Courtney D.
    Issa, Ghayas C.
    Sasaki, Koji
    Konopleva, Marina
    Pemmaraju, Naveen
    Chien, Kelly S.
    Ohanian, Maro
    Jabbour, Elias
    Maiti, Abhishek
    Roy, Edith
    Delumpa, Ricardo
    Rivera, Juan
    Loiselle, Christopher
    Banks, Glenda
    Kantarjian, Hagop
    Short, Nicholas
    BLOOD, 2022, 140 : 3880 - 3882
  • [25] PHASE II STUDY OF COMBINATION OF HYPERCVAD WITH PONATINIB IN FRONT LINE THERAPY OF PATIENTS (PTS) WITH PHILADELPHIA CHROMOSOME (PH) POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)
    Jabbour, E.
    Kantarjian, H.
    Thomas, D.
    Ravandi, F.
    Cortes, J.
    Hoehn, D.
    Pemmaraju, N.
    Kadia, T.
    Garris, R.
    Garcia-Manero, G.
    Borthakur, G.
    Wierda, W.
    O'Brien, S.
    HAEMATOLOGICA, 2014, 99 : 258 - 259
  • [26] Phase II Study of Combination of Hypercvad with Ponatinib in Front Line Therapy of Patients (pts) with Philadelphia Chromosome (Ph) Positive Acute Lymphoblastic Leukemia (ALL)
    Jabbour, Elias
    Kantarjian, Hagop M.
    Thomas, Deborah A.
    Sasaki, Koji
    Ravandi, Farhad
    Cortes, Jorge E.
    Pemmaraju, Naveen
    Kadia, Tapan
    Garris, Rebecca
    Garcia-Manero, Guillermo
    Borthakur, Gautam
    Wierda, William G.
    O'Brien, Susan
    BLOOD, 2014, 124 (21)
  • [27] Phase 1/2 clinical study of dasatinib in Japanese patients with chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia
    Hisashi Sakamaki
    Ken-ichi Ishizawa
    Masafumi Taniwaki
    Shin Fujisawa
    Yasuo Morishima
    Kensei Tobinai
    Masaya Okada
    Kiyoshi Ando
    Noriko Usui
    Shuichi Miyawaki
    Atae Utsunomiya
    Nobuhiko Uoshima
    Tadashi Nagai
    Tomoki Naoe
    Toshiko Motoji
    Itsuro Jinnai
    Mitsune Tanimoto
    Yasushi Miyazaki
    Kazunori Ohnishi
    Shinsuke Iida
    Shinichiro Okamoto
    Taku Seriu
    Ryuzo Ohno
    International Journal of Hematology, 2009, 89 : 332 - 341
  • [28] Phase 1/2 clinical study of dasatinib in Japanese patients with chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia
    Sakamaki, Hisashi
    Ishizawa, Ken-ichi
    Taniwaki, Masafumi
    Fujisawa, Shin
    Morishima, Yasuo
    Tobinai, Kensei
    Okada, Masaya
    Ando, Kiyoshi
    Usui, Noriko
    Miyawaki, Shuichi
    Utsunomiya, Atae
    Uoshima, Nobuhiko
    Nagai, Tadashi
    Naoe, Tomoki
    Motoji, Toshiko
    Jinnai, Itsuro
    Tanimoto, Mitsune
    Miyazaki, Yasushi
    Ohnishi, Kazunori
    Iida, Shinsuke
    Okamoto, Shinichiro
    Seriu, Taku
    Ohno, Ryuzo
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2009, 89 (03) : 332 - 341
  • [29] LINEAGE INVOLVEMENT OF BCR-ABL IN PHILADELPHIA-CHROMOSOME-POSITIVE (PH+) LYMPHOBLASTIC MALIGNANCIES - CHRONIC MYELOGENOUS LEUKEMIA (CML) PRESENTING IN LYMPHOID BLAST PHASE (CML-LBP) VS PH+ ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)
    ANASTASI, J
    FENG, J
    LEBEAU, MM
    RUBIN, CM
    LARSON, RA
    ROWLEY, JD
    VARDIMAN, JW
    LABORATORY INVESTIGATION, 1995, 72 (01) : A105 - A105
  • [30] A phase II study of dasatinib in patients with chronic myeloid leukemia (CML) in lymphoid blast crisis or Philadelphia-Chromosome positive acute lymphoblastic leukemia (Ph plus ALL) who are resistant or intolerant to imatinib: The 'START-L' CA180015 study.
    Ottmann, OG
    Martinelli, G
    Dombret, H
    Kantarjian, H
    Hochhaus, A
    Simonsson, B
    Aloe, A
    Apanovitch, A
    Shah, N
    BLOOD, 2005, 106 (11) : 17A - 17A
12345